These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27179267)

  • 1. Review of succinate dehydrogenase-deficient renal cell carcinoma with focus on clinical and pathobiological aspects.
    Kuroda N; Yorita K; Nagasaki M; Harada Y; Ohe C; Jeruc J; Raspollini MR; Michal M; Hes O; Amin MB
    Pol J Pathol; 2016 Mar; 67(1):3-7. PubMed ID: 27179267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Succinate Dehydrogenase-Deficient Renal Cell Carcinoma: A Short Review.
    Wang G; Rao P
    Arch Pathol Lab Med; 2018 Oct; 142(10):1284-1288. PubMed ID: 30281364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary succinate dehydrogenase-deficient renal cell carcinoma.
    Rogala J; Zhou M
    Semin Diagn Pathol; 2024 Jan; 41(1):32-41. PubMed ID: 37981479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Succinate dehydrogenase (SDH)-deficient renal cell carcinoma].
    Agaimy A
    Pathologe; 2016 Mar; 37(2):144-52. PubMed ID: 26979428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Succinate dehydrogenase A deficient renal cell carcinoma: A rare renal tumor distinct from typical Succinate dehydrogenase deficient renal cell carcinoma.
    Liu J; Wang Y; Wang X; Li Y; Jiang Y; Li Y; Zhang W; Yu W
    Pathol Res Pract; 2024 Sep; 261():155459. PubMed ID: 39083879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Succinate dehydrogenase B-deficient renal cell carcinoma: A case report with novel germline mutation.
    Iwashita H; Okudela K; Matsumura M; Yamanaka S; Sawazumi T; Enaka M; Udaka N; Miyake A; Hibiya T; Miyake N; Matsumoto N; Makiyama K; Yao M; Nagashima Y; Ohashi K
    Pathol Int; 2017 Nov; 67(11):585-589. PubMed ID: 28960644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma.
    Williamson SR; Eble JN; Amin MB; Gupta NS; Smith SC; Sholl LM; Montironi R; Hirsch MS; Hornick JL
    Mod Pathol; 2015 Jan; 28(1):80-94. PubMed ID: 25034258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel SDHA-deficient Renal Cell Carcinoma Revealed by Comprehensive Genomic Profiling.
    Yakirevich E; Ali SM; Mega A; McMahon C; Brodsky AS; Ross JS; Allen J; Elvin JA; Safran H; Resnick MB
    Am J Surg Pathol; 2015 Jun; 39(6):858-63. PubMed ID: 25724004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Succinate Dehydrogenase-Deficient Renal Cell Carcinoma.
    Tsai TH; Lee WY
    Arch Pathol Lab Med; 2019 May; 143(5):643-647. PubMed ID: 31026220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SDH-deficient renal cell carcinoma - clinical, pathologic and genetic correlates: a case report.
    Kumar R; Bonert M; Naqvi A; Zbuk K; Kapoor A
    BMC Urol; 2018 Nov; 18(1):109. PubMed ID: 30482207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Succinate dehydrogenase (SDH)-deficient neoplasia.
    Gill AJ
    Histopathology; 2018 Jan; 72(1):106-116. PubMed ID: 29239034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients.
    Gill AJ; Hes O; Papathomas T; Šedivcová M; Tan PH; Agaimy A; Andresen PA; Kedziora A; Clarkson A; Toon CW; Sioson L; Watson N; Chou A; Paik J; Clifton-Bligh RJ; Robinson BG; Benn DE; Hills K; Maclean F; Niemeijer ND; Vlatkovic L; Hartmann A; Corssmit EP; van Leenders GJ; Przybycin C; McKenney JK; Magi-Galluzzi C; Yilmaz A; Yu D; Nicoll KD; Yong JL; Sibony M; Yakirevich E; Fleming S; Chow CW; Miettinen M; Michal M; Trpkov K
    Am J Surg Pathol; 2014 Dec; 38(12):1588-602. PubMed ID: 25025441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation.
    Miettinen M; Killian JK; Wang ZF; Lasota J; Lau C; Jones L; Walker R; Pineda M; Zhu YJ; Kim SY; Helman L; Meltzer P
    Am J Surg Pathol; 2013 Feb; 37(2):234-40. PubMed ID: 23282968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single nucleotide variants of succinate dehydrogenase A gene in renal cell carcinoma.
    Kamai T; Higashi S; Murakami S; Arai K; Namatame T; Kijima T; Abe H; Jamiyan T; Ishida K; Shirataki H; Yoshida KI
    Cancer Sci; 2021 Aug; 112(8):3375-3387. PubMed ID: 34014604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of succinate dehydrogenase and fumarate hydratase-deficient renal cell carcinoma based on immunohistochemical screening with SDHA/SDHB and FH/2SC.
    Gupta S; Swanson AA; Chen YB; Lopez T; Milosevic D; Kipp BR; Leibovich BC; Thompson RH; Herrera-Hernandez L; Cheville JC; Jimenez RE
    Hum Pathol; 2019 Sep; 91():114-122. PubMed ID: 31299266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Succinate Dehydrogenase (SDH)-Deficient Pancreatic Neuroendocrine Tumor Expands the SDH-Related Tumor Spectrum.
    Niemeijer ND; Papathomas TG; Korpershoek E; de Krijger RR; Oudijk L; Morreau H; Bayley JP; Hes FJ; Jansen JC; Dinjens WN; Corssmit EP
    J Clin Endocrinol Metab; 2015 Oct; 100(10):E1386-93. PubMed ID: 26259135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal carcinoma associated with a novel succinate dehydrogenase A mutation: a case report and review of literature of a rare subtype of renal carcinoma.
    Ozluk Y; Taheri D; Matoso A; Sanli O; Berker NK; Yakirevich E; Balasubramanian S; Ross JS; Ali SM; Netto GJ
    Hum Pathol; 2015 Dec; 46(12):1951-5. PubMed ID: 26476567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
    Gill AJ
    Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients.
    Fuchs TL; Maclean F; Turchini J; Vargas AC; Bhattarai S; Agaimy A; Hartmann A; Kao CS; Ellis C; Bonert M; Leroy X; Kunju LP; Schwartz L; Matsika A; Williamson SR; Rao P; Divatia M; Guarch R; Algaba F; Balancin ML; Zhou M; Samaratunga H; da Cunha IW; Brimo F; Ryan A; Clouston D; Aron M; O'Donnell M; Chan E; Hirsch MS; Moch H; Pang CY; Wah C; Yin W; Perry-Keene J; Yilmaz A; Chou A; Clarkson A; van der Westhuizen G; Morrison E; Zwi J; Hes O; Trpkov K; Gill AJ
    Mod Pathol; 2022 Jun; 35(6):836-849. PubMed ID: 34949766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis.
    Papathomas TG; Gaal J; Corssmit EP; Oudijk L; Korpershoek E; Heimdal K; Bayley JP; Morreau H; van Dooren M; Papaspyrou K; Schreiner T; Hansen T; Andresen PA; Restuccia DF; van Kessel I; van Leenders GJ; Kros JM; Looijenga LH; Hofland LJ; Mann W; van Nederveen FH; Mete O; Asa SL; de Krijger RR; Dinjens WN
    Eur J Endocrinol; 2014 Jan; 170(1):1-12. PubMed ID: 24096523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.